$80.4 Billion is the total value of OppenheimerFunds, Inc.'s 3573 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
FEYE | FIREEYE INC | $100,747,000 | +3.6% | 6,000,441 | 0.0% | 0.12% | -10.1% | |
NVRO | NEVRO CORP | $93,765,000 | +60.7% | 1,500,000 | 0.0% | 0.12% | +41.0% | |
BB | BLACKBERRY LTD | $40,360,000 | +41.9% | 4,000,000 | 0.0% | 0.05% | +22.0% | |
BTG | B2GOLD CORP | $29,449,000 | -3.8% | 10,480,000 | 0.0% | 0.04% | -15.9% | |
GWPH | GW PHARMACEUTICALS PLCads | $16,857,000 | +73.1% | 100,000 | 0.0% | 0.02% | +50.0% | |
HALO | HALOZYME THERAPEUTICS INC | $16,100,000 | +10.0% | 1,000,000 | 0.0% | 0.02% | -4.8% | |
RIGL | RIGEL PHARMACEUTICALS INC | $12,850,000 | +11.7% | 5,000,000 | 0.0% | 0.02% | 0.0% | |
HESM | HESS MIDSTREAM PARTNERS LPunit ltd pr int | $10,091,000 | +24.9% | 475,970 | 0.0% | 0.01% | +8.3% | |
GSS | GOLDEN STAR RES LTD CDA | $9,868,000 | +26.0% | 2,485,532 | 0.0% | 0.01% | +9.1% | |
XERS | XERIS PHARMACEUTICALS INC | $10,040,000 | -40.9% | 1,000,000 | 0.0% | 0.01% | -50.0% | |
ARLP | ALLIANCE RES PARTNER L Put ltd part | $8,348,000 | +17.4% | 410,013 | 0.0% | 0.01% | 0.0% | |
ACTG | ACACIA RESH CORP | $8,150,000 | +9.4% | 2,500,000 | 0.0% | 0.01% | -9.1% | |
GTES | GATES INDUSTRIAL CORPRATIN P | $5,063,000 | +8.3% | 353,101 | 0.0% | 0.01% | -14.3% | |
NGD | NEW GOLD INC CDA | $2,712,000 | +13.8% | 3,150,000 | 0.0% | 0.00% | 0.0% | |
GSV | GOLD STD VENTURES CORP | $1,898,000 | -18.4% | 1,861,112 | 0.0% | 0.00% | -33.3% | |
BASX | BASIC ENERGY SVCS INC NEW | $246,000 | -1.2% | 64,845 | 0.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- AXA Equitable Funds Management Group, LLC #1
- Brighthouse Investment Advisers, LLC #2
- Directed Services LLC #3
- JACKSON NATIONAL ASSET MANAGEMENT LLC #4
- Nationwide Fund Advisors #5
- OFI Advisors LLC #6
- OFI GLOBAL INSTITUTIONAL, INC #7
- OFI SteelPath, Inc. #8
- Pacific Life Fund Advisors LLC #9
- SUNAMERICA ASSET MANAGEMENT, LLC #10
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
APPLE INC | 25 | Q1 2019 | 2.3% |
BAIDU INC SPON ADR /1 AD | 25 | Q1 2019 | 2.9% |
CITIGROUP INC | 25 | Q1 2019 | 1.8% |
FACEBOOK INC-A | 25 | Q1 2019 | 1.9% |
ICICI BK LTD | 25 | Q1 2019 | 1.7% |
MICROSOFT CORP | 25 | Q1 2019 | 2.0% |
JPMORGAN CHASE & CO | 25 | Q1 2019 | 1.5% |
MAGELLAN MIDSTREAM PRTNRS LP | 25 | Q1 2019 | 1.2% |
UNITEDHEALTH GROUP INC | 25 | Q1 2019 | 1.2% |
CHEVRON CORP NEW | 25 | Q1 2019 | 1.4% |
View OppenheimerFunds, Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Americas Silver CorpSold out | May 10, 2019 | 0 | 0.0% |
resTORbio, Inc. | April 10, 2019 | 4,316,546 | 12.2% |
Huazhu Group Ltd | March 08, 2019 | 29,955,154 | 10.3% |
TransMontaigne Partners LLCSold out | March 08, 2019 | 0 | 0.0% |
BUCKEYE PARTNERS, L.P. | February 08, 2019 | 14,927,413 | 10.2% |
SUBURBAN PROPANE PARTNERS LP | February 08, 2019 | 6,300,758 | 10.2% |
Blueknight Energy Partners, L.P. | January 30, 2019 | 2,980,165 | 7.2% |
CSI Compressco LP | January 24, 2019 | 5,595,493 | 12.5% |
GasLog Partners LP | January 24, 2019 | 2,442,539 | 5.4% |
GLOBAL PARTNERS LP | January 24, 2019 | 4,935,927 | 14.5% |
View OppenheimerFunds, Inc.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
4 | 2024-05-03 |
4 | 2024-05-02 |
4 | 2023-10-04 |
3 | 2023-09-15 |
4 | 2023-09-15 |
13F-HR | 2019-05-13 |
SC 13G/A | 2019-05-10 |
SC 13G | 2019-04-10 |
SC 13G/A | 2019-03-08 |
SC 13G/A | 2019-03-08 |
View OppenheimerFunds, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.